7876 logo

Obigen Pharma Inc. Stock Price

TPEX:7876 Community·NT$4.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

7876 Share Price Performance

NT$37.00
-6.20 (-14.35%)
NT$37.00
-6.20 (-14.35%)
Price NT$37.00

7876 Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with low risk.

3 Risks
0 Rewards

Obigen Pharma Inc. Key Details

NT$0

Revenue

NT$0

Cost of Revenue

NT$0

Gross Profit

NT$414.3m

Other Expenses

-NT$414.3m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
-3.86
0%
0%
0%
View Full Analysis

About 7876

Founded
2020
Employees
60
CEO
Peifen Chou
WebsiteView website
www.obigenpharma.com

Obigen Pharma Inc. engages in research, manufacturing, and promotion of biotechnology and novel botulinum toxin. Preparations in Taiwan. Its lead product OBI-858, a 760 kDa novel toxin protein which fermented and purified from clostridium botulinum type A bacteria, which is in Phase II clinical trial. The company was founded in 2020 and is based in Zhubei, Taiwan.

Recent 7876 News & Updates

Recent updates

No updates